CUTIVATE

This brand name is authorized in Cyprus, Ecuador, Estonia, Hong Kong, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug CUTIVATE contains one active pharmaceutical ingredient (API):

1 Fluticasone UNII O2GMZ0LF5W - FLUTICASONE PROPIONATE

Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically. Read about Fluticasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CUTIVATE Lotion	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07AC17	Fluticasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 24.370-1-01-12
Country: EE	Ravimiamet	Identifier(s): 1004847, 1006344, 1062087, 1062098
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 158443
Country: HK	Department of Health Drug Office	Identifier(s): 37755
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000528, 1000530, 1022726, 1022727, 1079991, 1079992, 1081957, 1081958, 1084826, 1084875, 1085199, 1085794, 1087810, 1087811
Country: MT	Medicines Authority	Identifier(s): MA192/03801
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 210M97
Country: NL	Z-Index G-Standaard	Identifier(s): 13803735
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 38626, 38628, 38636
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100016334, 100016340
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65211001, W65212001
Country: SG	Health Sciences Authority	Identifier(s): 08628P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522385041
Country: US	FDA, National Drug Code	Identifier(s): 10337-333, 10337-434
Country: ZA	Health Products Regulatory Authority	Identifier(s): 27/13.4.1/0441, 27/13.4.1/0442